Linda Dwoskin, PhD, director of the CCTS Drug Discovery & Development Core and Endowed Professor in Pharmaceutical Education at the University of Kentucky College of Pharmacy, was interviewed about her work to develop the first-ever medication to reduce craving and relapse in methamphetamine use disorder.
Jeffrey Talbert, PhD, associate director of the CCTS, interim director of CCTS Biomedical Informatics Core, and director of the UK Institute for Pharmaceutical Outcomes and Policy, presented his research at the Annual RX Drug Abuse and Heroin Summit in D.C.
The conference focused on the science of health policy and systems change as strategies for population-level health improvement. Researchers, clinicians, students, community partners, and local and national experts gathered Monday, April 15th to share findings, disseminate best practices, and catalyze collaborations.
The ACT Network provides a real-time, open-access, no-cost platform for researchers throughout the CTSA consortium to explore and validate feasibility for clinical studies using aggregated electronic health record data from over 100 million patients nationwide.